Article
Protein engineering of Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase into parkeol synthase.
Organic letters - 19 Oct 2012
Liu Yuan-Ting, Hu Tain-Chang, Chang Cheng-Hsiang, Shie Wen-Shiang, Wu Tung-Kung
Abstract excerpt
A Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase mutant, ERG7(T384Y/Q450H/V454I), produced parkeol but not lanosterol as the sole end product. Parkeol undergoes downstream metabolism to generate compounds 9 and 10. In vitro incubation of parkeol produced a product profile similar to that of the in vivo experiment. In summary, parkeol undergoes a metabolic pathway similar to that of cycloartenol in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
